Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

High plasma nesfatin-1 level in patients with major depressive disorder.

Ari M, Ozturk OH, Bez Y, Oktar S, Erduran D.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30;35(2):497-500. doi: 10.1016/j.pnpbp.2010.12.004. Epub 2010 Dec 14.

PMID:
21163317
2.

Plasma nesfatin 1 level in patients with first attack psychosis.

Sahpolat M, Ari M.

Bratisl Lek Listy. 2017;118(2):77-79. doi: 10.4149/BLL_2017_015.

PMID:
28814086
3.

Increased plasma nesfatin-1 levels may be associated with corticosterone, IL-6, and CRP levels in patients with major depressive disorder.

Xia QR, Liang J, Cao Y, Shan F, Liu Y, Xu YY.

Clin Chim Acta. 2018 May;480:107-111. doi: 10.1016/j.cca.2018.02.004. Epub 2018 Feb 7.

PMID:
29427582
4.

Plasma nesfatin-1 concentrations in restricting-type anorexia nervosa.

Ogiso K, Asakawa A, Amitani H, Nakahara T, Ushikai M, Haruta I, Koyama K, Amitani M, Harada T, Yasuhara D, Inui A.

Peptides. 2011 Jan;32(1):150-3. doi: 10.1016/j.peptides.2010.10.004. Epub 2010 Oct 19.

PMID:
20937336
5.

The newly identified anorexigenic adipokine nesfatin-1 in hemodialysis patients: Are there associations with food intake, body composition and inflammation?

Saldanha JF, Carrero JJ, Lobo JC, Stockler-Pinto MB, Leal VO, Calixto A, Geloneze B, Mafra D.

Regul Pept. 2012 Jan 10;173(1-3):82-5. doi: 10.1016/j.regpep.2011.09.010. Epub 2011 Oct 26.

PMID:
22036920
6.

NUCB2/nesfatin-1 is associated with elevated scores of anxiety in female obese patients.

Hofmann T, Stengel A, Ahnis A, Buße P, Elbelt U, Klapp BF.

Psychoneuroendocrinology. 2013 Nov;38(11):2502-10. doi: 10.1016/j.psyneuen.2013.05.013. Epub 2013 Jun 21.

PMID:
23796625
7.

Decreased plasma nesfatin-1 levels in patients with generalized anxiety disorder.

Gunay H, Tutuncu R, Aydin S, Dag E, Abasli D.

Psychoneuroendocrinology. 2012 Dec;37(12):1949-53. doi: 10.1016/j.psyneuen.2012.04.007. Epub 2012 May 15.

PMID:
22595767
8.

[Analysis of serum levels of nesfatin-1 in children and adolescents with autoimmune thyroid diseases].

Sawicka B, Bossowski A.

Pediatr Endocrinol Diabetes Metab. 2013;19(1):5-10. Polish.

PMID:
23739643
9.

Time-dependent changes in the serum levels of prolactin, nesfatin-1 and ghrelin as a marker of epileptic attacks young male patients.

Aydin S, Dag E, Ozkan Y, Arslan O, Koc G, Bek S, Kirbas S, Kasikci T, Abasli D, Gokcil Z, Odabasi Z, Catak Z.

Peptides. 2011 Jun;32(6):1276-80. doi: 10.1016/j.peptides.2011.04.021. Epub 2011 Apr 30.

PMID:
21554911
10.

Major depressive disorder is associated with cardiovascular risk factors and low Omega-3 Index.

Baghai TC, Varallo-Bedarida G, Born C, Häfner S, Schüle C, Eser D, Rupprecht R, Bondy B, von Schacky C.

J Clin Psychiatry. 2011 Sep;72(9):1242-7. doi: 10.4088/JCP.09m05895blu. Epub 2010 Dec 14.

PMID:
21208589
11.

A novel appetite peptide, nesfatin-1 in patients with non-alcoholic fatty liver disease.

Başar O, Akbal E, Köklü S, Koçak E, Tuna Y, Ekiz F, Gültuna S, Yιlmaz FM, Aydoğan T.

Scand J Clin Lab Invest. 2012 Oct;72(6):479-83. doi: 10.3109/00365513.2012.699097. Epub 2012 Sep 5.

PMID:
22950627
12.

Decreased cerebrospinal fluid/plasma ratio of the novel satiety molecule, nesfatin-1/NUCB-2, in obese humans: evidence of nesfatin-1/NUCB-2 resistance and implications for obesity treatment.

Tan BK, Hallschmid M, Kern W, Lehnert H, Randeva HS.

J Clin Endocrinol Metab. 2011 Apr;96(4):E669-73. doi: 10.1210/jc.2010-1782. Epub 2011 Jan 20.

PMID:
21252251
13.

Serum nesfatin-1 levels in overt and subclinical hyperthyroidism.

Gungunes A, Ozbek M, Ginis Z, Sahin M, Demirci T, Cakir Ozkaya E, Karbek B, Sayki Arslan M, Ozturk Unsal I, Tutal Akkaya E, Ucan B, Gultuna Ozguclu S, Cakal E, Topaloglu O, Delibasi T.

Minerva Endocrinol. 2014 Sep;39(3):209-14.

PMID:
25068306
14.

Serum brain-derived neurotrophic factor level in dysthymia: a comparative study with major depressive disorder.

Aydemir O, Deveci A, Taskin OE, Taneli F, Esen-Danaci A.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jun 30;31(5):1023-6. Epub 2007 Mar 6.

PMID:
17433517
15.

Plasma levels of brain-derived neurotrophic factor and interleukin-6 in patients with dysthymic disorder: comparison with age- and sex-matched major depressed patients and healthy controls.

Yoshimura R, Umene-Nakano W, Hoshuyama T, Ikenouchi-Sugita A, Hori H, Katsuki A, Hayashi K, Atake K, Nakamura J.

Hum Psychopharmacol. 2010 Nov;25(7-8):566-9. doi: 10.1002/hup.1155.

PMID:
21312291
17.
18.

Decreased plasma nesfatin-1 levels in patients with acute myocardial infarction.

Dai H, Li X, He T, Wang Y, Wang Z, Wang S, Xing M, Sun W, Ding H.

Peptides. 2013 Aug;46:167-71. doi: 10.1016/j.peptides.2013.06.006. Epub 2013 Jun 24.

PMID:
23806888
19.

Decreased serum nesfatin-1 levels in endometriosis.

Şengül Ö, Dilbaz B, Halıcı Z, Ferah I, Çadırcı E, Yılmaz F.

Eur J Obstet Gynecol Reprod Biol. 2014 Jun;177:34-7. doi: 10.1016/j.ejogrb.2014.03.012. Epub 2014 Mar 15.

PMID:
24702902
20.

Plasma nesfatin-1 level in obese patients after acupuncture: a randomised controlled trial.

Guo Y, Xing M, Sun W, Yuan X, Dai H, Ding H.

Acupunct Med. 2014 Aug;32(4):313-7. doi: 10.1136/acupmed-2014-010530. Epub 2014 May 9.

PMID:
24813558

Supplemental Content

Support Center